Click here to get full coverage on Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on How (AUPH) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

How (AUPH) Movements Inform Risk Allocation Models  news.stocktradersdaily.com

How (AUPH) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Click here to get full coverage on Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified  simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Click here to get full coverage on Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ)  Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Click here to get full coverage on Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - sharewise.com

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?  sharewise.com

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - sharewise.com

Click here to get full coverage on New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target  Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

Click here to get full coverage on Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - The Motley Fool

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?  The Motley Fool

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - The Motley Fool

Click here to get full coverage on Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC - MarketBeat

Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC  MarketBeat

Aurinia Pharmaceuticals Inc $AUPH Shares Purchased by Jump Financial LLC - MarketBeat

Click here to get full coverage on A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains - simplywall.st

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains  simplywall.st

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains - simplywall.st

Click here to get full coverage on Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Yahoo Finance

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge  Yahoo Finance

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives - simplywall.st

Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives  simplywall.st

Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives - simplywall.st

Click here to get full coverage on Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?  Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Click here to get full coverage on With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns  Yahoo Finance

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Yahoo Finance

Click here to get full coverage on What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?  Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Click here to get full coverage on Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know  Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Click here to get full coverage on Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock? - simplywall.st

Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock?  simplywall.st

Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock? - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug  Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Click here to get full coverage on Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating  Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Click here to get full coverage on $AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data.  Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March  Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025 - Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025  Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025 - Business Wire

Click here to get full coverage on Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week  simplywall.st

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Click here to get full coverage on The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH)  Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now?  Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts  MarketBeat

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Click here to get full coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why - MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why  MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why - MarketBeat

Click here to get full coverage on Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares  Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Click here to get full coverage on Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Business Wire

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025  Business Wire

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Business Wire

Click here to get full coverage on (AUPH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

(AUPH) and the Role of Price-Sensitive Allocations  news.stocktradersdaily.com

(AUPH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Click here to get full coverage on Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality  simplywall.st

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years  富途牛牛

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛

Click here to get full coverage on Aurinia Responds to Now Retracted LinkedIn Post - Business Wire

Aurinia Responds to Now Retracted LinkedIn Post  Business Wire

Aurinia Responds to Now Retracted LinkedIn Post - Business Wire

Click here to get full coverage on First Week of AUPH July 2026 Options Trading - Nasdaq

First Week of AUPH July 2026 Options Trading  Nasdaq

First Week of AUPH July 2026 Options Trading - Nasdaq

Click here to get full coverage on Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha

Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH)  Seeking Alpha

Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha

Click here to get full coverage on Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns - Investing.com

Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns  Investing.com

Leerink Partners downgrades Aurinia Pharmaceuticals stock rating on growth concerns - Investing.com

Click here to get full coverage on FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’  Stocktwits

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits

Click here to get full coverage on Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Schroder Investment Management Group Has $4.64 Million Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week  simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

Click here to get full coverage on Jefferies upgrades Aurinia Pharmaceuticals stock to Buy on strong Lupkynis sales - Investing.com

Jefferies upgrades Aurinia Pharmaceuticals stock to Buy on strong Lupkynis sales  Investing.com

Jefferies upgrades Aurinia Pharmaceuticals stock to Buy on strong Lupkynis sales - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations  Yahoo Finance

Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Click here to get full coverage on Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - TradingView — Track All Markets

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options  TradingView — Track All Markets

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - TradingView — Track All Markets

Click here to get full coverage on Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - Business Wire

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025  Business Wire

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed? - simplywall.st

Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed?  simplywall.st

Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD  Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com

Click here to get full coverage on State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

State Board of Administration of Florida Retirement System Has $1.22 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView — Track All Markets

Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4  TradingView — Track All Markets

Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView — Track All Markets

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress  Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Click here to get full coverage on Aurinia downgraded at RBC on risk-reward setup - MSN

Aurinia downgraded at RBC on risk-reward setup  MSN

Aurinia downgraded at RBC on risk-reward setup - MSN

Click here to get full coverage on Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com

Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target  Investing.com

Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com

Click here to get full coverage on at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire

at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025  Business Wire

at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks

Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance  TipRanks

Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks

Click here to get full coverage on Aurinia Pharma director Tang buys $13.59m in shares - Investing.com

Aurinia Pharma director Tang buys $13.59m in shares  Investing.com

Aurinia Pharma director Tang buys $13.59m in shares - Investing.com

Click here to get full coverage on FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - Yahoo Finance

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech  Yahoo Finance

FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance - TipRanks

Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance  TipRanks

Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView — Track All Markets

Aurinia Pharmaceuticals Inc. SEC 10-Q Report  TradingView — Track All Markets

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView — Track All Markets

Click here to get full coverage on Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD - Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD  Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD - Investing.com

Click here to get full coverage on Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Business Wire

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)  Business Wire

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Business Wire

Click here to get full coverage on Leerink Partners reiterates Outperform rating on Aurinia stock after trial data - Investing.com

Leerink Partners reiterates Outperform rating on Aurinia stock after trial data  Investing.com

Leerink Partners reiterates Outperform rating on Aurinia stock after trial data - Investing.com

Click here to get full coverage on Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery  Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - Stocktwits

Click here to get full coverage on Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks

Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results  TipRanks

Aurinia Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction - TipRanks

Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction  TipRanks

Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates  sharewise.com

AUPH

Price Chart

Key Statistics

Technicals

About AUPH

Latest News

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

How (AUPH) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Armistice Capital LLC Sells 3,370,400 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Advanced Charts

Top Gainers

Top Losers